zero-tolerance-policy-on-'fake-drug'-in-india,-mansukh-mandaviya-said-notice-to-71-pharma-companies
New Delhi : Union Health Minister Mansukh Mandaviya on Tuesday said that India has a "zero tolerance" on spurious drugs. Follows the policy of. He said that after concerns were expressed in some quarters about deaths allegedly caused by cough syrup made in India to stop cough Show cause notices have been issued to the companies. He said that out of 84 companies to whom notices have been issued, has been asked to close. India cautious about production of quality medicines In an exclusive interview with news agency Bhasha, Health Minister Mansukh Mandaviya said that to ensure quality drug production in the country, continuous comprehensive analysis is done and the government and regulators are always working to ensure that We are alert that no one should die due to fake medicines. He said that we are the pharmacy of the world and we want to assure everyone that we are the 'Quality Pharmacy of the World'. Cough syrup from India to Gambia and Uzbekistan 84 Death of children According to the agency's report, in February of this year Tamil Nadu's Global Pharma Healthcare had recalled the entire consignment of its eye drops. Earlier, it was alleged that children in Gambia and Uzbekistan 84 died last year from cough syrup made in India. . In this Gambia's and Uzbekistan's 20 Children are involved. from 4355in India 2022 .Export of cough syrup worth $6 billion in agency report It is stated that India 2022- in 17.6 exported cough syrups worth billion US dollars, while -20 export it in 11 billion US dollars. Overall, India is the largest supplier of generic drugs globally, meeting the global demand for various vaccines per cent, about 23 per cent of generic demand in the US and about 25 supplies per cent medicines. could not produce any factsUnion Health Minister Mansukh Mandaviya said whenever some questions are raised about Indian medicines, we need to get into facts . For example in The Gambia, it was said that children had died. Somebody in WHO said this and we wrote to them what are the facts. Nobody came to us with facts. He said that we examined the samples of a company. We tried to know the cause of death and found that the child had diarrhoea. If a child has diarrhoea, who advised cough syrup for that child? 4355435523 Only four of the samples failedHealth Minister Mandaviya said that a total of 23 samples were taken, out of which four failed. He said the question is if just one batch was made for export and if it fails, all the samples will fail. It is not possible that 23 samples pass and four samples fail Go. Still, we're cautious. We are continuing with risk-based analysis to ensure quality production of medicines in our country.

You can share this post!

Related News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

New Delhi : Union Health Minister Mansukh Mandaviya on Tuesday said that India has a “zero tolerance” on spurious drugs. Follows the policy of. He said that after concerns were expressed in some quarters about deaths allegedly caused by cough syrup made in India to stop cough Show cause notices have been issued to the companies. He said that out of 84 companies to whom notices have been issued, has been asked to close. India cautious about production of quality medicines In an exclusive interview with news agency Bhasha, Health Minister Mansukh Mandaviya said that to ensure quality drug production in the country, continuous comprehensive analysis is done and the government and regulators are always working to ensure that We are alert that no one should die due to fake medicines. He said that we are the pharmacy of the world and we want to assure everyone that we are the ‘Quality Pharmacy of the World’.

Cough syrup from India to Gambia and Uzbekistan 84 Death of children

According to the agency’s report, in February of this year Tamil Nadu’s Global Pharma Healthcare had recalled the entire consignment of its eye drops. Earlier, it was alleged that children in Gambia and Uzbekistan 84 died last year from cough syrup made in India. . In this Gambia’s and Uzbekistan’s 20 Children are involved.

from 4355in India 2022 .Export of cough syrup worth $6 billion

in agency report It is stated that India 2022- in 17.6 exported cough syrups worth billion US dollars, while -20 export it in 11 billion US dollars. Overall, India is the largest supplier of generic drugs globally, meeting the global demand for various vaccines per cent, about 23 per cent of generic demand in the US and about 25 supplies per cent medicines.

could not produce any factsUnion Health Minister Mansukh Mandaviya said whenever some questions are raised about Indian medicines, we need to get into facts . For example in The Gambia, it was said that children had died. Somebody in WHO said this and we wrote to them what are the facts. Nobody came to us with facts. He said that we examined the samples of a company. We tried to know the cause of death and found that the child had diarrhoea. If a child has diarrhoea, who advised cough syrup for that child?

4355435523 Only four of the samples failedHealth Minister Mandaviya said that a total of 23 samples were taken, out of which four failed. He said the question is if just one batch was made for export and if it fails, all the samples will fail. It is not possible that 23 samples pass and four samples fail Go. Still, we’re cautious. We are continuing with risk-based analysis to ensure quality production of medicines in our country.